S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

RGLS Regulus Therapeutics Inc

1.56

0.15 (10.64%)

After Hours

Last Updated: 16:10:25

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Regulus Therapeutics Charts.

Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Regulus Therapeutics Charts.

Regulus Therapeutics Inc News

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (4 days ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (5 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (5 days ago) • Edgar (US Regulatory)

Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates
Thursday 7 November 2024 (5 days ago) • PR Newswire (US)

Form 8-K - Current report
Thursday 24 October 2024 (3 weeks ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 11 October 2024 (1 month ago) • Edgar (US Regulatory)

Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Tuesday 8 October 2024 (1 month ago) • PR Newswire (US)

Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences
Wednesday 28 August 2024 (3 months ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 8 August 2024 (3 months ago) • Edgar (US Regulatory)

Regulus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Updates
Thursday 8 August 2024 (3 months ago) • PR Newswire (US)

Regulus Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference
Tuesday 6 August 2024 (3 months ago) • PR Newswire (US)

More Regulus Therapeutics Inc News Articles

Regulus Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions